Robotic Radiosurgery System Market Size, Share, & COVID-19 Impact Analysis | Global | 2022-2028 | MedCore | Includes: Capital Equipment and 2 more

In 2021, the global robotic radiosurgery system market was valued at $419.5 million. This is anticipated to rise over the forecast period at a CAGR of 11.5% to reach $901.6 million.

The full report suite on the global market for robotic radiosurgery systems includes two main segments: capital equipment and services and maintenance revenue. Regional volumes of robotic radiosurgery procedures are also included and reported.

MARKET REPORT DATA TYPES INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends

• Procedure Numbers

• COVID-19 Impact Analysis

• Market Drivers & Limiters

• Market Forecasts Until 2028, and Historical Data to 2018

• Recent Mergers & Acquisitions

• Company Profiles and Product Portfolios

• Leading Competitors

PROCEDURE NUMBERS

The global robotic radiosurgery market experienced a substantial increase in the number of procedures performed in 2021. In 2020, the market undertook a slower growth in procedure volume as a result of the Global COVID-19 pandemic.

GLOBAL ROBOTIC RADIOSURGERY SYSTEM MARKET TRENDS

A general trend that is being seen across all segments of the surgical robotics market is the increasing usage of robots during surgery, especially for surgical robots that have the ability to perform minimally invasive surgery.

GLOBAL ROBOTIC RADIOSURGERY SYSTEM MARKET SHARE INSIGHTS

The Global Robotic Radiosurgery System market has only one dominant competitor: Accuray. While there are some other radiosurgery systems on the market with robotic components, Accuray's CyberKnife® is the only true robot on the market. In addition to its traditional uses, the system may also be used for neurological indications through the company's partnership with Brainlab.

GLOBAL ROBOTIC RADIOSURGERY SYSTEM MARKET SEGMENTATION SUMMARY

• Capital Equipment
• Services Revenue
• Maintenance Revenue

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States)

• Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)

• Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)

• Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)

• Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)

• Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)

• Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

• Base Year: 2021
• Forecast Period: 2022-2028
• Historical Data: 2018-2021

• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices

• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios

• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

Read more about iData's 9-Step Research Methodology.

WHY CHOOSE IDATA?

• Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

• Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

• Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

• Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.